Publications by authors named "S Mansard"

Claim this Profile
I
Impact of melanoma histological regression on first-line immunotherapy response in stage-IV disease.
Jean-Baptiste Such, Sandrine Mansard, Mélissa Zlobecki, Carole Chevenet, Céline Lambert

J Eur Acad Dermatol Venereol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain metastases from Merkel cell carcinoma: A nationwide retrospective study.
Raphaëlle Caillot, Astrid Blom, Céleste Lebbé, Laetitia Da Meda, Marie Boileau, Sandrine Mansard

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).
Charlée Nardin, Charlotte Cavalieri, Céleste Lebbé, Emilie Gérard, Marc Puyraveau, Sandrine Mansard

Br J Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAF or BRAF mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study.
Caroline Robert, Michal Kicinski, Caroline Dutriaux, Émilie Routier, Anne-Sophie Govaerts, Sandrine Mansard

Lancet Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and hypofractionated radiotherapy in patients with advanced melanoma: A phase 2 trial.
Jérôme Doyen, Anne Dompmartin, Coralie Cruzel, Dinu Stefan, Jean-Philippe Arnault, Sandrine Mansard

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis